Therefore, doses of 2 and 8 mg/kg, b.i.d. (4 and 16 mg/kg/day) were selected for the repeated dosing study to examine the anti-NASH effect of GS-0976 in MC4R KO mice. Here, MC4R is linked to metabolic dysfunction-associated steatohepatitis.